BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 7655872)

  • 1. Urate-oxidase for the treatment of tophaceous gout in heart transplant recipients. A report of three cases.
    Rozenberg S; Roche B; Dorent R; Koeger AC; Borget C; Wrona N; Bourgeois P
    Rev Rhum Engl Ed; 1995 May; 62(5):392-4. PubMed ID: 7655872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Uricolytic therapy. Value of urate oxidase in the treatment of hyperuricemias].
    Potaux L; Aparicio M; Maurel C; Ruedas ME; Martin-Dupont Cl
    Nouv Presse Med; 1975 Apr; 4(15):1109-12. PubMed ID: 1094413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
    Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
    Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study.
    Sundy JS; Becker MA; Baraf HS; Barkhuizen A; Moreland LW; Huang W; Waltrip RW; Maroli AN; Horowitz Z;
    Arthritis Rheum; 2008 Sep; 58(9):2882-91. PubMed ID: 18759308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout.
    Sundy JS; Ganson NJ; Kelly SJ; Scarlett EL; Rehrig CD; Huang W; Hershfield MS
    Arthritis Rheum; 2007 Mar; 56(3):1021-8. PubMed ID: 17328081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory gout: what is it and what to do about it?
    Fels E; Sundy JS
    Curr Opin Rheumatol; 2008 Mar; 20(2):198-202. PubMed ID: 18349751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Data on changes in blood and urinary uric acid induced by a urate oxidase].
    Villiaumey J; Larget-Piet B; Rotterdam M
    Rev Rhum Mal Osteoartic; 1972 Feb; 39(2):138-40. PubMed ID: 4563394
    [No Abstract]   [Full Text] [Related]  

  • 8. A survey of indications, results and complications of surgery for tophaceous gout.
    Kumar S; Gow P
    N Z Med J; 2002 Jul; 115(1158):U109. PubMed ID: 12362184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uric acid and its metabolism].
    Kissel P; Royer R
    Presse Med (1893); 1968 Dec; 76(49):2317-8. PubMed ID: 5737248
    [No Abstract]   [Full Text] [Related]  

  • 10. [Uricosuric agent].
    Ohno I
    Nihon Rinsho; 2008 Apr; 66(4):743-7. PubMed ID: 18409525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New trend in gout treatment. Clinical and biological study of urate oxidase].
    Mizon JP; Plaquet R; Gentit F; Quiret JC
    Lille Med; 1971 Nov; 16(9):1332-45. PubMed ID: 4945000
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?
    Li-Yu J; Clayburne G; Sieck M; Beutler A; Rull M; Eisner E; Schumacher HR
    J Rheumatol; 2001 Mar; 28(3):577-80. PubMed ID: 11296962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzbromarone therapy in management of refractory gout.
    Kumar S; Ng J; Gow P
    N Z Med J; 2005 Jun; 118(1217):U1528. PubMed ID: 15980902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawal of longterm antihyperuricemic therapy in tophaceous gout.
    van Lieshout-Zuidema MF; Breedveld FC
    J Rheumatol; 1993 Aug; 20(8):1383-5. PubMed ID: 8230024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pegloticase and the patient with treatment-failure gout.
    Dave AJ; Kelly VM; Krishnan E
    Expert Rev Clin Pharmacol; 2012 Sep; 5(5):501-8. PubMed ID: 23121270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modalities of purine excretion during enzyme treatment of gout and other hyperuricemic conditions with urate oxidase].
    Royer R; Vindel J; Lamarche M; Kissel P
    Presse Med (1893); 1968 Dec; 76(49):2325-7. PubMed ID: 5737250
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experience with a new uricolytic agent].
    Alessandri C; Violi F; Bonavita MS
    Recenti Prog Med; 1986 Mar; 77(3):147-8. PubMed ID: 3715181
    [No Abstract]   [Full Text] [Related]  

  • 18. Finger pad tophi in gout.
    Holland NW; Jost D; Beutler A; Schumacher HR; Agudelo CA
    J Rheumatol; 1996 Apr; 23(4):690-2. PubMed ID: 8730128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uricosuric therapy and urate solubility in blood and urine.
    Gröbner W; Zöllner N
    Postgrad Med J; 1979; 55 Suppl 3():26-31. PubMed ID: 504037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gout: on the brink of novel therapeutic options for an ancient disease.
    Bieber JD; Terkeltaub RA
    Arthritis Rheum; 2004 Aug; 50(8):2400-14. PubMed ID: 15334451
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.